Skip to main content
Fig. 1 | Breast Cancer Research

Fig. 1

From: High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer

Fig. 1

CONSORT diagram of the studied patients, number of patients with available tissue for each marker, and number of M0 patients per marker available for survival analysis. BOOG, Borstkanker Onderzoek Groep; EORTC, European Organisation for Research and Treatment of Cancer; CXCR4, C-X-C chemokine receptor type 4; CXCL12, C-X-C motif chemokine 12; HGF, hepatocyte growth factor; M0, patients without metastases at diagnosis; M1, patients with metastases at diagnosis; Mx, patients with unknown metastatic status at diagnosis

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us